Trgovina OncoSec Medical Incorporated - ONCS CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.05 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | 0.4 |
Odpri* | 0.41 |
Enoletna sprememba* | -49.38% |
Dnevni razpon* | 0.4 - 0.41 |
Razpon 52 wk | 0.35-1.95 |
Povprečni obseg (10 dni) | 34.26K |
Povprečni obseg (3 meseci) | 487.04K |
Tržna kapitalizacija | 14.18M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 39.40M |
Prihodki | N/A |
EPS | -0.96 |
Dividenda (donosnost v %) | N/A |
Beta | 1.70 |
Datum naslednjega zaslužka | N/A |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Jun 7, 2023 | 0.40 | -0.01 | -2.44% | 0.41 | 0.43 | 0.40 |
Jun 6, 2023 | 0.41 | -0.01 | -2.38% | 0.42 | 0.43 | 0.40 |
Jun 5, 2023 | 0.42 | -0.01 | -2.33% | 0.43 | 0.43 | 0.41 |
Jun 2, 2023 | 0.43 | -0.01 | -2.27% | 0.44 | 0.44 | 0.41 |
Jun 1, 2023 | 0.44 | 0.01 | 2.33% | 0.43 | 0.44 | 0.42 |
May 31, 2023 | 0.44 | 0.04 | 10.00% | 0.40 | 0.44 | 0.40 |
May 30, 2023 | 0.41 | -0.02 | -4.65% | 0.43 | 0.43 | 0.40 |
May 26, 2023 | 0.42 | -0.01 | -2.33% | 0.43 | 0.45 | 0.41 |
May 25, 2023 | 0.43 | -0.03 | -6.52% | 0.46 | 0.46 | 0.42 |
May 24, 2023 | 0.47 | -0.02 | -4.08% | 0.49 | 0.49 | 0.43 |
May 23, 2023 | 0.49 | -0.01 | -2.00% | 0.50 | 0.50 | 0.48 |
May 22, 2023 | 0.51 | 0.02 | 4.08% | 0.49 | 0.52 | 0.49 |
May 19, 2023 | 0.50 | 0.00 | 0.00% | 0.50 | 0.52 | 0.48 |
May 18, 2023 | 0.50 | -0.02 | -3.85% | 0.52 | 0.52 | 0.49 |
May 17, 2023 | 0.50 | -0.02 | -3.85% | 0.52 | 0.52 | 0.48 |
May 16, 2023 | 0.52 | -0.30 | -36.59% | 0.82 | 1.27 | 0.46 |
May 15, 2023 | 0.79 | 0.01 | 1.28% | 0.78 | 0.80 | 0.77 |
May 12, 2023 | 0.78 | 0.01 | 1.30% | 0.77 | 0.80 | 0.77 |
May 11, 2023 | 0.77 | -0.01 | -1.28% | 0.78 | 0.78 | 0.76 |
May 10, 2023 | 0.79 | 0.03 | 3.95% | 0.76 | 0.79 | 0.76 |
OncoSec Medical Incorporated Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
Wednesday, July 12, 2023 | ||
Čas (UTC) (UTC) 13:00 | Država US
| Dogodek OncoSec Medical Inc Annual Shareholders Meeting OncoSec Medical Inc Annual Shareholders MeetingForecast -Previous - |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
Prihodki | 0 | 0 | 0 | 0 | 0 |
Celotni odhodki iz poslovanja | 47.4193 | 43.4091 | 30.4167 | 38.5708 | 21.4484 |
Celotna prodaja/splošni/upravni stroški Odhodki | 14.2824 | 18.3123 | 11.9715 | 18.6898 | 9.49566 |
Raziskave in razvoj | 34.0976 | 25.0968 | 18.4452 | 17.4155 | 11.9528 |
Prihodki iz poslovanja | -47.4193 | -43.4091 | -30.4167 | -38.5708 | -21.4484 |
Čisti dobiček pred obdavčitvijo | -47.5799 | -43.126 | -30.2748 | -39.1357 | -21.4484 |
Čisti dobiček po davkih | -45.1677 | -42.2534 | -30.2761 | -39.1364 | -21.4498 |
Čisti dobiček pred dodatnimi postavkami | -45.1677 | -42.2534 | -30.2761 | -39.1364 | -21.4498 |
Čisti dobiček | -45.1677 | -42.2534 | -30.2761 | -39.1364 | -21.4498 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -45.1677 | -42.2534 | -30.2761 | -39.1364 | -21.4498 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -45.1677 | -42.2534 | -30.2761 | -39.1364 | -21.4498 |
Popravljen čisti dobiček | -45.1677 | -42.2534 | -30.2761 | -39.1364 | -21.4498 |
Popravljene ponderirane povprečne delnice | 32.9034 | 16.5345 | 7.05328 | 4.01234 | 2.01897 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -1.37274 | -2.55546 | -4.29248 | -9.75401 | -10.6241 |
Popravljen normalizirani dobiček na enoto čistega dobička | -1.39172 | -2.55546 | -4.29241 | -9.21285 | -10.6241 |
Nenavadni odhodki (prihodki) | -0.96079 | 0 | 2.4654 | ||
Gain (Loss) on Sale of Assets | -0.0007 | -0.8751 | |||
Drugo, neto | -0.0007 | 0.18505 | 0.44004 | 0.31017 | |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.15995 | 0.09803 | -0.29742 |
Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
Prihodki | 0 | 0 | 0 | 0 | 0 |
Celotni odhodki iz poslovanja | 9.54771 | 9.41643 | 9.91549 | 13.877 | 9.47614 |
Celotna prodaja/splošni/upravni stroški Odhodki | 2.51711 | 2.59089 | 3.26972 | 6.08384 | 2.84715 |
Raziskave in razvoj | 7.03061 | 6.82554 | 6.64577 | 7.79312 | 7.58978 |
Nenavadni odhodki (prihodki) | 0 | 0 | -0.96079 | ||
Prihodki iz poslovanja | -9.54771 | -9.41643 | -9.91549 | -13.877 | -9.47614 |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.03889 | -0.48545 | 0.10887 | -0.33439 | 0.03364 |
Drugo, neto | 0.00218 | -0.00258 | -0.00201 | -0.00136 | 0.00172 |
Čisti dobiček pred obdavčitvijo | -9.58442 | -9.90447 | -9.80863 | -14.2127 | -9.44078 |
Čisti dobiček po davkih | -6.24731 | -9.90742 | -9.80863 | -11.796 | -9.44233 |
Čisti dobiček pred dodatnimi postavkami | -6.24731 | -9.90742 | -9.80863 | -11.796 | -9.44233 |
Čisti dobiček | -6.24731 | -9.90742 | -9.80863 | -11.796 | -9.44233 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -6.24731 | -9.90742 | -9.80863 | -11.796 | -9.44233 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -6.24731 | -9.90742 | -9.80863 | -11.796 | -9.44233 |
Popravljen čisti dobiček | -6.24731 | -9.90742 | -9.80863 | -11.796 | -9.44233 |
Popravljene ponderirane povprečne delnice | 39.3557 | 39.3149 | 39.1773 | 39.0412 | 37.3356 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.15874 | -0.252 | -0.25036 | -0.30214 | -0.2529 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.15874 | -0.252 | -0.25036 | -0.30214 | -0.26963 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 49.1794 | 22.8217 | 28.5073 | 28.6218 | 12.5136 |
Denarna sredstva in kratkoročne naložbe | 45.9512 | 20.3545 | 25.1478 | 26.9781 | 11.4447 |
Denarna sredstva in ustrezniki | 45.9512 | 20.3545 | 25.1478 | 3.80363 | 11.4447 |
Prepaid Expenses | 3.22819 | 2.46722 | 3.35956 | 1.64375 | 1.06895 |
Other Current Assets, Total | 0 | ||||
Total Assets | 56.2759 | 29.9035 | 29.892 | 30.2465 | 15.2329 |
Property/Plant/Equipment, Total - Net | 6.37457 | 6.76272 | 1.03113 | 1.26566 | 2.4101 |
Property/Plant/Equipment, Total - Gross | 7.74135 | 7.93922 | 1.991 | 1.99518 | 3.23377 |
Accumulated Depreciation, Total | -1.36678 | -1.17651 | -0.95987 | -0.72951 | -0.82367 |
Other Long Term Assets, Total | 0.27352 | 0.31906 | 0.35355 | 0.35899 | 0.30919 |
Total Current Liabilities | 7.96192 | 9.67803 | 4.977 | 5.84964 | 3.39597 |
Payable/Accrued | 4.77889 | 3.28113 | |||
Accrued Expenses | 6.6021 | 8.61371 | 4.26432 | 0.23042 | 0.11484 |
Notes Payable/Short Term Debt | 0 | 0 | 0.08376 | 0 | 0 |
Total Liabilities | 18.2001 | 16.033 | 5.61291 | 7.32227 | 4.53693 |
Total Long Term Debt | 0 | 0.48055 | 0 | 0 | 0 |
Other Liabilities, Total | 10.2382 | 5.87444 | 0.63591 | 1.47263 | 1.14095 |
Total Equity | 38.0758 | 13.8704 | 24.2791 | 22.9242 | 10.696 |
Common Stock | 0.00392 | 0.00231 | 0.00106 | 0.00535 | 0.00216 |
Additional Paid-In Capital | 286.337 | 214.79 | 177.656 | 145.744 | 93.8661 |
Retained Earnings (Accumulated Deficit) | -248.186 | -200.902 | -153.547 | -122.809 | -83.1686 |
Total Liabilities & Shareholders’ Equity | 56.2759 | 29.9035 | 29.892 | 30.2465 | 15.2329 |
Total Common Shares Outstanding | 39.1526 | 23.0545 | 10.633 | 5.35116 | 2.16182 |
Other Equity, Total | -0.07911 | -0.0195 | 0.16904 | -0.01602 | -0.00362 |
Kratkoročne naložbe | 0 | 23.1744 | |||
Other Current Liabilities, Total | 0.12568 | 0.09481 | 0.62892 | 0.84032 | |
Current Port. of LT Debt/Capital Leases | 1.23413 | 0.96951 | |||
Long Term Debt | 0 | 0.48055 | |||
Intangibles, Net | 0.44841 |
Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 21.1359 | 27.9279 | 38.6905 | 49.1794 | 56.2424 |
Denarna sredstva in kratkoročne naložbe | 19.4775 | 25.231 | 35.7068 | 45.9512 | 54.3925 |
Denarna sredstva in ustrezniki | 19.4775 | 25.231 | 35.7068 | 45.9512 | 54.3925 |
Prepaid Expenses | 1.65844 | 2.6969 | 2.98373 | 3.22819 | 1.84985 |
Total Assets | 27.9942 | 35.0893 | 45.6249 | 56.2759 | 63.6341 |
Property/Plant/Equipment, Total - Net | 5.93417 | 6.22023 | 6.2255 | 6.37457 | 6.59176 |
Property/Plant/Equipment, Total - Gross | 7.44324 | 7.68203 | 7.63881 | 7.74135 | 7.91122 |
Accumulated Depreciation, Total | -1.50907 | -1.4618 | -1.41331 | -1.36678 | -1.31946 |
Intangibles, Net | 0.396 | 0.41347 | 0.43094 | 0.44841 | 0.46588 |
Other Long Term Assets, Total | 0.52809 | 0.52773 | 0.278 | 0.27352 | 0.3341 |
Total Current Liabilities | 4.6869 | 5.57153 | 6.86995 | 7.96192 | 5.73002 |
Accrued Expenses | 4.47166 | 4.99067 | 5.93309 | 6.6021 | 5.72107 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.12476 | 0.49722 | 0.86701 | 1.23413 | 0 |
Other Current Liabilities, Total | 0.09049 | 0.08364 | 0.06985 | 0.12568 | 0.00895 |
Total Liabilities | 14.1056 | 15.2741 | 16.8462 | 18.2001 | 16.2221 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Long Term Debt | 0 | 0 | |||
Other Liabilities, Total | 9.41867 | 9.70262 | 9.97628 | 10.2382 | 10.4921 |
Total Equity | 13.8886 | 19.8152 | 28.7787 | 38.0758 | 47.412 |
Common Stock | 0.00394 | 0.00394 | 0.00392 | 0.00392 | 0.00389 |
Additional Paid-In Capital | 287.856 | 287.54 | 286.979 | 286.337 | 284.067 |
Retained Earnings (Accumulated Deficit) | -274.15 | -267.902 | -257.995 | -248.186 | -236.303 |
Other Equity, Total | 0.17873 | 0.17387 | -0.2095 | -0.07911 | -0.35581 |
Total Liabilities & Shareholders’ Equity | 27.9942 | 35.0893 | 45.6249 | 56.2759 | 63.6341 |
Total Common Shares Outstanding | 39.3644 | 39.3493 | 39.2026 | 39.1526 | 38.8715 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -45.1677 | -42.2534 | -30.2761 | -39.1364 | -21.4498 |
Denarna sredstva iz poslovanja | -41.794 | -33.1454 | -29.004 | -23.2219 | -17.3404 |
Denarna sredstva iz poslovanja | 0.23686 | 0.21664 | 0.24371 | 0.33449 | 0.37999 |
Nedenarne postavke | 5.62916 | 5.119 | 4.57649 | 13.41 | 4.01679 |
Cash Taxes Paid | 0.00499 | 0.00245 | 0.0017 | 0.00068 | 0.00139 |
Denarna sredstva Plačane obresti | 0.0103 | 0.00318 | 0.00325 | 0 | 0 |
Spremembe v obratnem kapitalu | -2.49233 | 3.77243 | -3.54813 | 2.16993 | -0.28735 |
Denarna sredstva pri naložbenju | -0.7996 | 23.2039 | -23.2899 | -0.02156 | |
Kapitalski izdatki | -0.7996 | -0.00988 | -0.06516 | -0.02156 | |
Denarna sredstva pri financiranju | 68.209 | 28.3993 | 27.1985 | 38.8831 | 0.06401 |
Postavke denarnega toka pri financiranju | 0.54707 | -2.21814 | -1.20992 | -3.75725 | -0.0155 |
Izdaja (odplačilo) delnic, neto | 68.2811 | 29.803 | 28.49 | 42.6404 | 0.07951 |
Neto sprememba denarnih sredstev | 25.5968 | -4.79332 | 21.3442 | -7.64105 | -17.3015 |
Učinki deviznih tečajev | -0.01862 | -0.04728 | -0.05429 | -0.0124 | -0.00362 |
Celotne druge postavke denarnih tokov pri naložbenju | 23.2138 | -23.2247 | |||
Izdaja (odplačilo) dolga, neto | -0.61911 | 0.8145 | -0.08158 |
Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -25.9634 | -19.716 | -9.80863 | -45.1677 | -33.3717 |
Cash From Operating Activities | -25.2222 | -19.8815 | -9.86825 | -41.794 | -33.3874 |
Cash From Operating Activities | 0.1947 | 0.12996 | 0.064 | 0.23686 | 0.17207 |
Non-Cash Items | 2.27821 | 1.68754 | 0.62036 | 5.62916 | 3.03241 |
Cash Taxes Paid | 0.00295 | 0.00295 | 0 | 0.00499 | 0.00449 |
Cash Interest Paid | 0.01613 | 0.01343 | 0.00805 | 0.0103 | 0.00703 |
Changes in Working Capital | -1.73174 | -1.98294 | -0.74399 | -2.49233 | -3.22019 |
Cash From Investing Activities | -0.24486 | -0.24486 | -0.7996 | -0.75466 | |
Capital Expenditures | -0.24486 | -0.24486 | -0.7996 | -0.75466 | |
Cash From Financing Activities | -0.92133 | -0.54905 | -0.36762 | 68.209 | 68.1985 |
Financing Cash Flow Items | -0.01593 | -0.01612 | -0.0005 | 0.54707 | 0.56631 |
Issuance (Retirement) of Stock, Net | 0.20399 | 0.20399 | 0 | 68.2811 | 68.1295 |
Issuance (Retirement) of Debt, Net | -1.10938 | -0.73691 | -0.36712 | -0.61911 | -0.49732 |
Foreign Exchange Effects | -0.08538 | -0.04485 | -0.00861 | -0.01862 | -0.01836 |
Net Change in Cash | -26.4737 | -20.7202 | -10.2445 | 25.5968 | 34.038 |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group535K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$113M+
Mesečni obseg naložb
$64M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
OncoSec Medical Incorporated Company profile
O družbi OncoSec Medical Incorporated
OncoSec Medical Incorporated je biotehnološko podjetje v pozni fazi razvoja. Družba se osredotoča na oblikovanje, razvoj in trženje terapij in medicinskih pristopov za zdravljenje raka. Njena glavna tehnološka platforma, ImmunoPulse, je terapevtska modaliteta, ki jo sestavljajo naprave za intertumoralno elektroporacijo (EP), kot je naprava za elektroporacijo OncoSec Medical System (OMS) (OMS EP). Naprava OMS EP je zasnovana za dostavo zdravil, kodiranih v plazmidni DNK, neposredno v solidni tumor in spodbujanje imunološkega odziva proti raku. Naprava OMS EP se prilagaja za zdravljenje različnih vrst tumorjev in je sestavljena iz generatorja električnih impulzov, ročaja za večkratno uporabo in aplikatorjev za enkratno uporabo. Njen glavni kandidat za izdelek, TAVO, je kombinacija zdravila in naprave. Zdravilo je sestavljeno iz plazmidnega konstrukta, imenovanega tavokinogen telseplazmid (TAVO), z IL-12, kodiranim v plazmidni DNK, in se v tumor dostavi z njeno napravo za elektroporacijo.
Industry: | Biotechnology & Medical Research (NEC) |
24 N. Main Street
08534
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 535.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com